Coloplast A/S
OTC:CLPBF
Coloplast A/S
OTC:CLPBF
Price:
75.75
USD
Market Closed
Market Cap:
$17B
Balance Sheet
Balance Sheet Decomposition
Coloplast A/S
Coloplast A/S
Balance Sheet Decomposition is not available for
Coloplast A/S
Coloplast A/S
Balance Sheet
Coloplast A/S
Coloplast A/S
Currency: DKK
| Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | Sep-2024 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
546
|
314
|
297
|
356
|
323
|
448
|
414
|
911
|
788
|
947
|
|
| Cash |
546
|
314
|
297
|
356
|
323
|
448
|
414
|
911
|
788
|
947
|
|
| Short-Term Investments |
489
|
315
|
310
|
313
|
262
|
226
|
219
|
0
|
0
|
0
|
|
| Total Receivables |
3 028
|
3 190
|
3 085
|
3 581
|
3 514
|
3 720
|
4 659
|
5 120
|
5 550
|
5 176
|
|
| Accounts Receivables |
2 679
|
2 890
|
2 877
|
3 153
|
2 934
|
3 212
|
3 940
|
4 315
|
4 675
|
4 658
|
|
| Other Receivables |
349
|
300
|
208
|
428
|
580
|
508
|
719
|
805
|
875
|
518
|
|
| Inventory |
1 518
|
1 692
|
1 725
|
1 933
|
2 227
|
2 428
|
3 187
|
3 522
|
3 672
|
3 919
|
|
| Other Current Assets |
583
|
683
|
173
|
176
|
163
|
172
|
293
|
384
|
434
|
411
|
|
| Total Current Assets |
6 164
|
6 194
|
5 590
|
6 359
|
6 489
|
6 994
|
8 772
|
9 937
|
10 444
|
10 453
|
|
| PP&E Net |
2 925
|
3 072
|
3 169
|
3 249
|
3 926
|
4 386
|
5 151
|
5 979
|
6 571
|
7 085
|
|
| PP&E Gross |
2 925
|
3 072
|
3 169
|
3 249
|
3 926
|
4 386
|
5 151
|
5 979
|
6 571
|
7 085
|
|
| Accumulated Depreciation |
4 672
|
4 804
|
5 191
|
5 463
|
5 547
|
5 894
|
6 153
|
6 362
|
6 700
|
7 064
|
|
| Intangible Assets |
553
|
571
|
534
|
472
|
388
|
1 623
|
8 469
|
11 281
|
10 957
|
10 482
|
|
| Goodwill |
844
|
1 724
|
1 984
|
2 030
|
1 976
|
2 028
|
14 298
|
19 974
|
19 375
|
19 329
|
|
| Note Receivable |
15
|
15
|
22
|
27
|
24
|
26
|
31
|
39
|
28
|
341
|
|
| Long-Term Investments |
11
|
10
|
10
|
5
|
27
|
41
|
51
|
65
|
74
|
90
|
|
| Other Long-Term Assets |
495
|
464
|
460
|
590
|
669
|
743
|
674
|
884
|
624
|
587
|
|
| Other Assets |
844
|
1 724
|
1 984
|
2 030
|
1 976
|
2 028
|
14 298
|
19 974
|
19 375
|
19 329
|
|
| Total Assets |
11 007
N/A
|
12 050
+9%
|
11 769
-2%
|
12 732
+8%
|
13 499
+6%
|
15 841
+17%
|
37 446
+136%
|
48 159
+29%
|
48 073
0%
|
48 367
+1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
697
|
675
|
751
|
859
|
814
|
1 036
|
1 242
|
1 294
|
1 519
|
1 324
|
|
| Accrued Liabilities |
14
|
3
|
3
|
9
|
13
|
15
|
6
|
7
|
7
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
1 066
|
1 111
|
2 160
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
222
|
1 358
|
1 270
|
8
|
206
|
177
|
1 853
|
7 345
|
5 338
|
2 590
|
|
| Other Current Liabilities |
4 376
|
3 389
|
2 684
|
3 000
|
2 835
|
2 926
|
4 235
|
7 665
|
3 340
|
2 583
|
|
| Total Current Liabilities |
5 309
|
5 425
|
4 708
|
4 942
|
4 979
|
6 314
|
7 336
|
16 311
|
10 204
|
6 505
|
|
| Long-Term Debt |
0
|
98
|
91
|
134
|
430
|
449
|
16 855
|
12 222
|
17 291
|
20 049
|
|
| Deferred Income Tax |
106
|
253
|
282
|
264
|
369
|
671
|
4 567
|
2 122
|
2 481
|
3 042
|
|
| Other Liabilities |
524
|
322
|
270
|
479
|
315
|
239
|
396
|
205
|
155
|
2 649
|
|
| Total Liabilities |
5 939
N/A
|
6 098
+3%
|
5 351
-12%
|
5 819
+9%
|
6 093
+5%
|
7 673
+26%
|
29 154
+280%
|
30 860
+6%
|
30 131
-2%
|
32 245
+7%
|
|
| Equity | |||||||||||
| Common Stock |
216
|
216
|
216
|
216
|
216
|
216
|
216
|
228
|
228
|
228
|
|
| Retained Earnings |
4 889
|
5 767
|
6 399
|
6 925
|
7 505
|
8 385
|
8 571
|
18 227
|
19 222
|
17 675
|
|
| Other Equity |
37
|
31
|
197
|
228
|
315
|
433
|
495
|
1 156
|
1 508
|
1 781
|
|
| Total Equity |
5 068
N/A
|
5 952
+17%
|
6 418
+8%
|
6 913
+8%
|
7 406
+7%
|
8 168
+10%
|
8 292
+2%
|
17 299
+109%
|
17 942
+4%
|
16 122
-10%
|
|
| Total Liabilities & Equity |
11 007
N/A
|
12 050
+9%
|
11 769
-2%
|
12 732
+8%
|
13 499
+6%
|
15 841
+17%
|
37 446
+136%
|
48 159
+29%
|
48 073
0%
|
48 367
+1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
212
|
212
|
212
|
212
|
213
|
213
|
212
|
225
|
225
|
225
|
|
Switch to:
Switch to:
See Also
Discover More
